192 related articles for article (PubMed ID: 36358841)
1. UroVysion
Ke C; Hu Z; Yang C
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358841
[TBL] [Abstract][Full Text] [Related]
2. Bladder cancer detection using FISH (UroVysion assay).
Halling KC; Kipp BR
Adv Anat Pathol; 2008 Sep; 15(5):279-86. PubMed ID: 18724101
[TBL] [Abstract][Full Text] [Related]
3. UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives.
Nagai T; Naiki T; Etani T; Iida K; Noda Y; Shimizu N; Isobe T; Nozaki S; Okamura T; Ando R; Kawai N; Yasui T
Transl Androl Urol; 2021 Apr; 10(4):1908-1917. PubMed ID: 33968678
[TBL] [Abstract][Full Text] [Related]
4. The use of Urovysion fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder.
Reid-Nicholson MD; Ramalingam P; Adeagbo B; Cheng N; Peiper SC; Terris MK
Mod Pathol; 2009 Jan; 22(1):119-27. PubMed ID: 18978733
[TBL] [Abstract][Full Text] [Related]
5. Multiprobe fluorescence in situ hybridization (UroVysion) for the detection of urothelial carcinoma - FISHing for the right catch.
Bubendorf L
Acta Cytol; 2011; 55(2):113-9. PubMed ID: 21325794
[TBL] [Abstract][Full Text] [Related]
6. Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients.
Chuang KL; Chuang HC; Ng KF; Chang YH; Wu CT; Chuang CK; Liao SK; Pang ST
BJU Int; 2010 May; 105(10):1413-6. PubMed ID: 19818076
[TBL] [Abstract][Full Text] [Related]
7. UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study.
Dodurga Y; Avcı CB; Yılmaz S; Nazlı O; Coğulu O; Cankaya T; Gündüz C
Contemp Oncol (Pozn); 2013; 17(2):156-60. PubMed ID: 23788983
[TBL] [Abstract][Full Text] [Related]
8. The value of the UroVysion® FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens.
Virk RK; Abro S; de Ubago JMM; Pambuccian SE; Quek ML; Wojcik EM; Mehrotra S; Chatt GU; Barkan GA
Diagn Cytopathol; 2017 Jun; 45(6):481-500. PubMed ID: 28397365
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study.
Caraway NP; Khanna A; Fernandez RL; Payne L; Bassett RL; Zhang HZ; Kamat A; Katz RL
Cancer Cytopathol; 2010 Oct; 118(5):259-68. PubMed ID: 20665656
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of fluorescence in situ hybridization positive of exfoliated urothelial cells in urothelial carcinoma].
Liu JY; Peng X; Ning XH; Li T; Peng SH; Wang JY; Liu SJ; Ding Y; Cai L; Gong K
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):585-589. PubMed ID: 28816270
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Application of Fluorescence in Situ Hybridization in Diagnosing Urothelial Carcinoma.
Zhou H; Yan Y; Song L
Clin Lab; 2016 Oct; 62(10):2001-2009. PubMed ID: 28164542
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study.
Bonberg N; Taeger D; Gawrych K; Johnen G; Banek S; Schwentner C; Sievert KD; Wellhäußer H; Kluckert M; Leng G; Nasterlack M; Stenzl A; Behrens T; Brüning T; Pesch B;
BJU Int; 2013 Aug; 112(4):E372-82. PubMed ID: 23350736
[TBL] [Abstract][Full Text] [Related]
13. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.
Sokolova IA; Halling KC; Jenkins RB; Burkhardt HM; Meyer RG; Seelig SA; King W
J Mol Diagn; 2000 Aug; 2(3):116-23. PubMed ID: 11229514
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of fluorescence
Lin T; Liu Z; Liu L; Yang L; Han P; Zhang P; Wei Q
Oncol Lett; 2017 May; 13(5):3928-3934. PubMed ID: 28529600
[TBL] [Abstract][Full Text] [Related]
15. UroVysion
Ke C; Liu X; Wan J; Hu Z; Yang C
Front Mol Biosci; 2023; 10():1250442. PubMed ID: 37867556
[No Abstract] [Full Text] [Related]
16. [Clinical utility of fluorescence in situ hybridization improves the sensitivity in the diagnosis of upper urinary tract urothelial carcinoma].
Mu DW; Zhou LQ; Ding Y; He ZS; Wang Y; He Q; Yang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):381-5. PubMed ID: 20721247
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit).
Bravaccini S
Methods Mol Biol; 2021; 2292():35-48. PubMed ID: 33651350
[TBL] [Abstract][Full Text] [Related]
18. Positive urinary fluorescence
Guan B; Du Y; Su X; Cao Z; Li Y; Zhan Y; Peng D; Xiong G; Fang D; Ding Y; He S; Gong Y; He Q; Li X; Zhou L
Oncotarget; 2018 Mar; 9(18):14652-14660. PubMed ID: 29581871
[TBL] [Abstract][Full Text] [Related]
19. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
20. Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients.
Nagai T; Okamura T; Yanase T; Chaya R; Moritoki Y; Kobayashi D; Akita H; Yasui T
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1271-1273. PubMed ID: 31030505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
